Advertisement

Clinical characteristics and surgical outcomes of spinal myxopapillary ependymomas

  • Tie Liu
  • Chenlong Yang
  • Xiaofeng Deng
  • Anqi Li
  • Yu Xin
  • Jun Yang
  • Yulun XuEmail author
Original Article
  • 73 Downloads

Abstract

Spinal myxopapillary ependymoma (SME) is a rare pathological variant of ependymoma, which most commonly occurs in the cauda equina and filum terminale of the spinal cord. Although SME is considered as a benign entity, histologically corresponding to WHO grade I, local recurrence and metastasis have been reported in many cases. The purpose of this large-scale, single-center study was to investigate the clinical characteristics and surgical outcomes of SME. A total of 34 consecutive patients diagnosed with SME were enrolled in this retrospective study. All patients underwent magnetic resonance imaging (MRI) and were treated with surgical resection. Individual clinical data were collected, and surgical outcomes were evaluated during the follow-up period. There were 21 males and 13 females, with an average age of 29.97 years. Clinical symptoms included back pain (82.4%), weakness (44.1%) and numbness (20.6%) in extremities, and sphincter dysfunction (26.5%). The tumor locations included lumbar segments (52.9%), thoracolumbar segments (23.5%), lumbosacral segments (17.6%), and thoraco-lumbo-sacral segments (5.9%). On MRI, all SMEs appeared hypointense on T1-weighted imaging and hyperintense on T2-weighted imaging, with remarkable enhancement. Gross total resection was achieved in 18 patients, and subtotal resection (STR) was achieved in 16 patients. After an average follow-up period of 41.5 months, recurrence was noted in 5 patients (5 of 16) who underwent STR. SMEs have some characteristic features on MRI which can facilitate the preoperative diagnosis. Complete surgical resection is the best treatment of choice with a favorable outcome. In cases of incomplete resection, postoperative radiotherapy may be an effective alternative.

Keywords

Myxopapillary ependymoma Spinal tumor MRI Surgical resection Prognosis 

Notes

Acknowledgments

We thank all of the patients and their families who trusted us, and all of the physicians and staff members who helped in this study.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Aghakhani N, David P, Parker F, Lacroix C, Benoudiba F, Tadie M (2008) Intramedullary spinal ependymomas: analysis of a consecutive series of 82 adult cases with particular attention to patients with no preoperative neurological deficit. Neurosurgery 62:1279–1285; discussion 1285-1276.  https://doi.org/10.1227/01.neu.0000333299.26566.15 CrossRefPubMedGoogle Scholar
  2. 2.
    Akyurek S, Chang EL, Yu TK, Little D, Allen PK, McCutcheon I, Mahajan A, Maor MH, Woo SY (2006) Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M.D. Anderson Cancer Center. J Neuro-Oncol 80:177–183.  https://doi.org/10.1007/s11060-006-9169-2 CrossRefGoogle Scholar
  3. 3.
    Bagley CA, Kothbauer KF, Wilson S, Bookland MJ, Epstein FJ, Jallo GI (2007) Resection of myxopapillary ependymomas in children. J Neurosurg 106:261–267.  https://doi.org/10.3171/ped.2007.106.4.261 CrossRefPubMedGoogle Scholar
  4. 4.
    Bagley CA, Wilson S, Kothbauer KF, Bookland MJ, Epstein F, Jallo GI (2009) Long term outcomes following surgical resection of myxopapillary ependymomas. Neurosurg Rev 32:321–334; discussion 334.  https://doi.org/10.1007/s10143-009-0190-8 CrossRefPubMedGoogle Scholar
  5. 5.
    Chan MD, McMullen KP (2012) Multidisciplinary management of intracranial ependymoma. Curr Probl Cancer 36:6–19.  https://doi.org/10.1016/j.currproblcancer.2011.10.013 CrossRefPubMedGoogle Scholar
  6. 6.
    Clover LL, Hazuka MB, Kinzie JJ (1993) Spinal cord ependymomas treated with surgery and radiation therapy. A review of 11 cases. Am J Clin Oncol 16:350–353CrossRefPubMedGoogle Scholar
  7. 7.
    Fegerl G, Marosi C (2012) Stabilization of metastatic myxopapillary ependymoma with sorafenib. Rare Tumors 4:e42.  https://doi.org/10.4081/rt.2012.e42 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Feldman WB, Clark AJ, Safaee M, Ames CP, Parsa AT (2013) Tumor control after surgery for spinal myxopapillary ependymomas: distinct outcomes in adults versus children: a systematic review. J Neurosurg Spine 19:471–476.  https://doi.org/10.3171/2013.6.SPINE12927 CrossRefPubMedGoogle Scholar
  9. 9.
    Fujiwara Y, Manabe H, Izumi B, Shima T, Adachi N (2018) Remarkable efficacy of temozolomide for relapsed spinal myxopapillary ependymoma with multiple recurrence and cerebrospinal dissemination: a case report and literature review. Eur Spine J 27:421–425.  https://doi.org/10.1007/s00586-017-5413-z CrossRefPubMedGoogle Scholar
  10. 10.
    Gagliardi FM, Cervoni L, Domenicucci M, Celli P, Salvati M (1993) Ependymomas of the filum terminale in childhood: report of four cases and review of the literature. Childs Nerv Syst 9:3–6CrossRefPubMedGoogle Scholar
  11. 11.
    Garcia DM (1985) Primary spinal cord tumors treated with surgery and postoperative irradiation. Int J Radiat Oncol Biol Phys 11:1933–1939CrossRefPubMedGoogle Scholar
  12. 12.
    Hanbali F, Fourney DR, Marmor E, Suki D, Rhines LD, Weinberg JS, McCutcheon IE, Suk I, Gokaslan ZL (2002) Spinal cord ependymoma: radical surgical resection and outcome. Neurosurgery 51:1162–1172 discussion 1172-1164CrossRefPubMedGoogle Scholar
  13. 13.
    Kernohan J (1932) Primary tumors of the spinal cord and intradural filum terminale. Cytol Cell Pathol Nervous Syst 3Google Scholar
  14. 14.
    Klekamp J (2015) Spinal ependymomas. Part 2: Ependymomas of the filum terminale. Neurosurg Focus 39:E7.  https://doi.org/10.3171/2015.5.FOCUS15151 CrossRefPubMedGoogle Scholar
  15. 15.
    Kraetzig T, McLaughlin L, Bilsky MH, Laufer I (2018) Metastases of spinal myxopapillary ependymoma: unique characteristics and clinical management. J Neurosurg Spine 28:201–208.  https://doi.org/10.3171/2017.5.SPINE161164 CrossRefPubMedGoogle Scholar
  16. 16.
    Lim SC, Jang SJ (2006) Myxopapillary ependymoma of the fourth ventricle. Clin Neurol Neurosurg 108:211–214CrossRefPubMedGoogle Scholar
  17. 17.
    Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820.  https://doi.org/10.1007/s00401-016-1545-1 CrossRefGoogle Scholar
  18. 18.
    Maruyama R, Koga K, Nakahara T, Kishida K, Nabeshima K (1992) Cerebral myxopapillary ependymoma. Hum Pathol 23:960–962CrossRefPubMedGoogle Scholar
  19. 19.
    McCormick PC, Torres R, Post KD, Stein BM (1990) Intramedullary ependymoma of the spinal cord. J Neurosurg 72:523–532.  https://doi.org/10.3171/jns.1990.72.4.0523 CrossRefPubMedGoogle Scholar
  20. 20.
    Mork SJ, Loken AC (1977) Ependymoma: a follow-up study of 101 cases. Cancer 40:907–915CrossRefPubMedGoogle Scholar
  21. 21.
    Nakamura M, Ishii K, Watanabe K, Tsuji T, Matsumoto M, Toyama Y, Chiba K (2009) Long-term surgical outcomes for myxopapillary ependymomas of the cauda equina. Spine (Phila Pa 1976) 34:E756–E760.  https://doi.org/10.1097/BRS.0b013e3181b34d16 CrossRefGoogle Scholar
  22. 22.
    Rege SV, Narayan S, Patil H, Songara A (2016) Spinal myxopapillary ependymoma with interval drop metastasis presenting as cauda equina syndrome: case report and review of literature. J Spine Surg 2:216–221.  https://doi.org/10.21037/jss.2016.08.06 CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Sonneland PR, Scheithauer BW, Onofrio BM (2015) Myxopapillary ependymoma. A clinicopathologic and immunocytochemical study of 77 cases. Cancer 56:883–893CrossRefGoogle Scholar
  24. 24.
    Thoriya PJ, Watal P, Bahri NU, Rathod K (2015) Primary spinal primitive neuroectodermal tumor on MR imaging. Indian J Radiol Imaging 25:459–463.  https://doi.org/10.4103/0971-3026.169451 CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Thurnher MM (2009) 2007 World Health Organization classification of tumours of the central nervous system. Cancer Imaging 9(A):S1–S3.  https://doi.org/10.1102/1470-7330.2009.9001
  26. 26.
    Tseng YC, Hsu HL, Jung SM, Chen CJ (2004) Primary intracranial myxopapillary ependymomas: report of two cases and review of the literature. Acta Radiol 45:344–347CrossRefPubMedGoogle Scholar
  27. 27.
    Verstegen MJ, Bosch DA, Troost D (1997) Treatment of ependymomas. Clinical and non-clinical factors influencing prognosis: a review. Br J Neurosurg 11:542–553CrossRefPubMedGoogle Scholar
  28. 28.
    Warnick RE, Raisanen J, Adornato BT, Prados MD, Davis RL, Larson DA, Gutin PH (1993) Intracranial myxopapillary ependymoma: case report. J Neuro-Oncol 15:251–256CrossRefGoogle Scholar
  29. 29.
    Whitaker SJ, Bessell EM, Ashley SE, Bloom HJ, Bell BA, Brada M (1991) Postoperative radiotherapy in the management of spinal cord ependymoma. J Neurosurg 74:720–728.  https://doi.org/10.3171/jns.1991.74.5.0720 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Neurosurgery, Beijing Tiantan HospitalCapital Medical UniversityBeijingChina
  2. 2.China National Clinical Research Center for Neurological Diseases (NCRC-ND)BeijingChina
  3. 3.Department of OrthopedicsPeking University Third HospitalBeijingChina

Personalised recommendations